NKTREUR Nektar Therapeutics

held by 1 manager in Q1 2018

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	7.00%	1.3 yr	Reduce 35.0%	$127M	1,192,300

Search